Thus, although SDF-1 is less studied in psoriasis than in tumors, and the underlying molecular mechanisms remain unclear, SDF-1 is still a promising target in the cutaneous EIME to inhibit keratinocyte proliferation and subsequently treat or prevent the occurrence of psoriasis. The gene discussed is CXCL12; the disease is psoriasis.